Moving Closer to a Strep Vaccine

Researchers from the University of California have identified a possible solution to the often damaging immune response casued by strep for future strep vaccine Group A Streptococcus (strep) is estimated to cost the US $2 billion annually thanks to lost time and productivity amongst its work force.   Whilst for most, the only symptom of strep will be a painful …

An interview with Dr Rappuoli on the vaccine industry

As part of a series of interviews conducted with leading speakers of the World Vaccine Congress in Washington D.C., Terrapinn were delighted to sit down with Dr Rino Rappuoli, Global Head of Vaccines Research at Novartis Vaccines and Diagnostics. The conversation delved into the future role of big pharma in vaccines, how to deal with anti-vaccine rhetoric and what big …